查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1356827

转染技术市场报告：2030 年趋势、预测与竞争分析

Tranfection Technology Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

转染技术趋势与预测

到 2030 年，全球转染技术市场预计将达到 27 亿美元，2024 年至 2030 年年复合成长率为 7.1%。市场的主要驱动因素是慢性病盛行率的增加和细胞疗法投资的增加。全球转染技术市场前景广阔，治疗药物传递、医学研究和蛋白质生产市场都有机会。

转染技术市场洞察

Lucintel 预测基于试剂的方法将在预测期内实现高速成长。

预计生物医学研究将在预测期内实现最高成长。

由于感染疾病的流行、细胞产品的使用增加以及主要企业的存在，预计北美在预测期内将出现最高的增长。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些，由于材料或产品替代导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球转染技术市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球转染技术市场趋势（2018-2023）与预测（2024-2030）
  • 按方法分類的全球转染技术市场
    • 基于试剂的方法
    • 基于仪器的方法
    • 其他的
  • 按技术分類的全球转染技术市场
    • 物理转染
    • 基于生物化学的转染
    • 基于病毒载体的转染
  • 全球转染技术市场（按应用）
    • 治疗实施
    • 生物医学研究
    • 蛋白质生产
  • 以最终用途分類的全球转染技术市场
    • 研究中心和学术机构
    • 医院和诊所
    • 製药和生物技术公司
    • 其他的

第4章2018-2030年分地区市场趋势及预测分析

  • 全球转染技术市场区域分布
  • 北美转染技术市场
  • 欧洲转染技术市场
  • 亚太转染技术市场
  • 其他区域转染技术市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 按方法分類的全球转染技术市场成长机会
    • 全球转染技术市场成长机会（按技术）
    • 全球转染技术市场成长机会（按应用）
    • 以最终用途分類的全球转染技术市场成长机会
    • 按地区分類的全球转染技术市场成长机会
  • 全球转染技术市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 扩大全球转染技术市场的产能
    • 全球转染技术市场的合併、收购与合资企业
    • 认证和许可

第7章主要企业概况

  • Life Technologies
  • Sigma Aldrich
  • Lonza
  • Promega
  • Qiagen
  • Bio-Rad
  • Roche
  • Polyplus Transfection
  • Mirius Bio
  • Maxcyte
简介目录

Tranfection Technology Trends and Forecast

The future of the global tranfection technology market looks promising with opportunities in the therapeutic delivery, bio-medical research, and protein production markets. The global tranfection technology market is expected to reach an estimated $2.7 billion by 2030 with a CAGR of 7.1% from 2024 to 2030. The major drivers for this market are growing prevalence of chronic diseases and rising investment in cell-based therapies.

A more than 150-page report is developed to help in your business decisions.

Tranfection Technology by Segment

The study includes a forecast for the global tranfection technology by method, technology, application, end use, and region.

Tranfection Technology Market by Method [Shipment Analysis by Value from 2018 to 2030]:

  • Reagent-Based Method
  • Instrument-Based Method
  • Others

Tranfection Technology Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • Physical Transfection
  • Biochemical Based Transfection
  • Viral-Vector Based Transfection

Tranfection Technology Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Therapeutic Delivery
  • Bio-Medical Research
  • Protein Production

Tranfection Technology Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Research Centers and Academic Institutes
  • Hospitals and Clinics
  • Pharmaceutical and Biotechnology Companies
  • Others

Tranfection Technology Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Tranfection Technology Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies tranfection technology companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the tranfection technology companies profiled in this report include-

  • Life Technologies
  • Sigma Aldrich
  • Lonza
  • Promega
  • Qiagen
  • Bio-Rad
  • Roche
  • Polyplus Transfection
  • Mirius Bio
  • Maxcyte

Tranfection Technology Market Insights

Lucintel forecasts that reagent-based method is expected to witness higher growth over the forecast period.

Bio-medical research is expected to witness highest growth over the forecast period.

North America is expected to witness highest growth over the forecast period due to rising prevalence of infectious diseases, growing use of cell-based products, and presence of key players in the region.

Features of the Global Tranfection Technology Market

Market Size Estimates: Tranfection technology market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Tranfection technology market by various segments, such as by method, technology, application, end use, and region. in terms of($B).

Regional Analysis: Tranfection technology market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different methods, technologies, applications, end uses, and region.s for the tranfection technology market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the tranfection technology market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the tranfection technology market size?

Answer: The global tranfection technology market is expected to reach an estimated $2.7 billion by 2030.

Q.2. What is the growth forecast for tranfection technology market?

Answer: The global tranfection technology market is expected to grow with a CAGR of 7.1% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the tranfection technology market?

Answer: The major drivers for this market are growing prevalence of chronic diseases and rising investment in cell-based therapies.

Q.4. What are the major segments for tranfection technology market?

Answer: The future of the tranfection technology market looks promising with opportunities in the therapeutic delivery, bio-medical research, and protein production markets.

Q.5. Who are the key tranfection technology market companies?

Answer: Some of the key tranfection technology companies are as follows:

  • Life Technologies
  • Sigma Aldrich
  • Lonza
  • Promega
  • Qiagen
  • Bio-Rad
  • Roche
  • Polyplus Transfection
  • Mirius Bio
  • Maxcyte

Q.6. Which tranfection technology market segment will be the largest in future?

Answer: Lucintel forecasts that reagent-based method is expected to witness higher growth over the forecast period.

Q.7. In tranfection technology market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to rising prevalence of infectious diseases, growing use of cell-based products, and presence of key players in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the tranfection technology market by method (reagent-based method, instrument-based method, and others), technology (physical transfection, biochemical based transfection, and viral-vector based transfection), application (therapeutic delivery, bio-medical research, and protein production), end use (research centers and academic institutes, hospitals and clinics, pharmaceutical & biotechnology companies, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Tranfection Technology Market: Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Tranfection Technology Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Tranfection Technology Market by Method
    • 3.3.1: Reagent-Based Method
    • 3.3.2: Instrument-Based Method
    • 3.3.3: Others
  • 3.4: Global Tranfection Technology Market by Technology
    • 3.4.1: Physical Transfection
    • 3.4.2: Biochemical Based Transfection
    • 3.4.3: Viral-Vector Based Transfection
  • 3.5: Global Tranfection Technology Market by Application
    • 3.5.1: Therapeutic Delivery
    • 3.5.2: Bio-Medical Research
    • 3.5.3: Protein Production
  • 3.6: Global Tranfection Technology Market by End Use
    • 3.6.1: Research Centers and Academic Institutes
    • 3.6.2: Hospitals and Clinics
    • 3.6.3: Pharmaceutical and Biotechnology Companies
    • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Tranfection Technology Market by Region
  • 4.2: North American Tranfection Technology Market
    • 4.2.2: North American Tranfection Technology Market by Application: Therapeutic Delivery, Bio-Medical Research, and Protein Production
  • 4.3: European Tranfection Technology Market
    • 4.3.1: European Tranfection Technology Market by Method: Reagent-Based Method, Instrument-Based Method, and Others
    • 4.3.2: European Tranfection Technology Market by Application: Therapeutic Delivery, Bio-Medical Research, and Protein Production
  • 4.4: APAC Tranfection Technology Market
    • 4.4.1: APAC Tranfection Technology Market by Method: Reagent-Based Method, Instrument-Based Method, and Others
    • 4.4.2: APAC Tranfection Technology Market by Application: Therapeutic Delivery, Bio-Medical Research, and Protein Production
  • 4.5: ROW Tranfection Technology Market
    • 4.5.1: ROW Tranfection Technology Market by Method: Reagent-Based Method, Instrument-Based Method, and Others
    • 4.5.2: ROW Tranfection Technology Market by Application: Therapeutic Delivery, Bio-Medical Research, and Protein Production

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Tranfection Technology Market by Method
    • 6.1.2: Growth Opportunities for the Global Tranfection Technology Market by Technology
    • 6.1.3: Growth Opportunities for the Global Tranfection Technology Market by Application
    • 6.1.4: Growth Opportunities for the Global Tranfection Technology Market by End Use
    • 6.1.5: Growth Opportunities for the Global Tranfection Technology Market by Region
  • 6.2: Emerging Trends in the Global Tranfection Technology Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Tranfection Technology Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Tranfection Technology Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Life Technologies
  • 7.2: Sigma Aldrich
  • 7.3: Lonza
  • 7.4: Promega
  • 7.5: Qiagen
  • 7.6: Bio-Rad
  • 7.7: Roche
  • 7.8: Polyplus Transfection
  • 7.9: Mirius Bio
  • 7.10: Maxcyte